Linked Data API

Show Search Form

Search Results

225891
registered interest false more like this
date less than 2015-03-09more like thismore than 2015-03-09
answering body
Department for Education more like this
answering dept id 60 more like this
answering dept short name Education more like this
answering dept sort name Education more like this
hansard heading Schools: Uniforms more like this
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Education, if she will (a) review guidance on school uniforms and (b) bring forward legislative proposals to make such guidance statutory. more like this
tabling member constituency Washington and Sunderland West more like this
tabling member printed
Mrs Sharon Hodgson remove filter
uin 226675 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-16more like thismore than 2015-03-16
answer text <p>The Department for Education’s best practice guidance on school uniform was revised in September 2013. This revised guidance places greater emphasis on securing the best value for money in the supply of school uniforms. It is scheduled for review in summer 2015.</p><p> </p><p> </p><p> </p><p>The guidance is published online at:</p><p> </p><p><a href="http://www.gov.uk/government/publications/school-uniform" target="_blank">www.gov.uk/government/publications/school-uniform</a></p><p> </p> more like this
answering member constituency Yeovil more like this
answering member printed Mr David Laws more like this
question first answered
less than 2015-03-16T16:16:59.437Zmore like thismore than 2015-03-16T16:16:59.437Z
answering member
1473
label Biography information for Mr David Laws more like this
tabling member
1521
label Biography information for Mrs Sharon Hodgson more like this
225892
registered interest false more like this
date less than 2015-03-09more like thismore than 2015-03-09
answering body
Department for Education more like this
answering dept id 60 more like this
answering dept short name Education more like this
answering dept sort name Education more like this
hansard heading Schools: Uniforms more like this
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Education, what steps her Department is taking to ensure that school uniforms in all state-funded schools are affordable. more like this
tabling member constituency Washington and Sunderland West more like this
tabling member printed
Mrs Sharon Hodgson remove filter
uin 226676 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-16more like thismore than 2015-03-16
answer text <p>The Department for Education has issued guidance for all schools on the need to consider the cost and availability of the uniform.</p><p> </p><p> </p><p> </p><p>The guidance emphasises the importance of ensuring that uniform is widely available and affordable for parents. It sets out that governing bodies should be able to demonstrate that they have obtained the best value for money from suppliers, and that any savings negotiated with suppliers should be passed on to parents wherever possible. It also makes clear that compulsory branded items should be kept to a minimum, and that schools should avoid frequent changes to the uniform.</p><p> </p><p> </p><p> </p><p>Local authorities and academies have discretion within their budgets to provide school clothing grants or offer other help with the cost of school clothing in cases of financial hardship.</p><p> </p><p>The school uniform guidance is published online at:</p><p> </p><p><a href="http://www.gov.uk/government/publications/school-uniform" target="_blank">www.gov.uk/government/publications/school-uniform</a></p><p> </p>
answering member constituency Yeovil more like this
answering member printed Mr David Laws more like this
question first answered
less than 2015-03-16T16:14:35.85Zmore like thismore than 2015-03-16T16:14:35.85Z
answering member
1473
label Biography information for Mr David Laws more like this
tabling member
1521
label Biography information for Mrs Sharon Hodgson more like this
225622
registered interest false more like this
date less than 2015-03-06more like thismore than 2015-03-06
answering body
Department for Education more like this
answering dept id 60 more like this
answering dept short name Education more like this
answering dept sort name Education more like this
hansard heading Food Technology more like this
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Education, what assessment she has made of the effect on the educational and social progress of a child being unable to pay for ingredients and equipment for food technology lessons. more like this
tabling member constituency Washington and Sunderland West more like this
tabling member printed
Mrs Sharon Hodgson remove filter
uin 226579 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-03-16more like thismore than 2015-03-16
answer text <p>Schools play a key role in educating all children about the importance and benefits of eating well and staying healthy. This is why we have strengthened the requirements on schools to teach children about food, nutrition and healthy eating and how to cook a repertoire of dishes from an early age. In the new national curriculum, learning about food is a key component for every child and food preparation and nutrition lessons are compulsory up to the age of 14. We expect schools to find ways to enable all pupils to participate in food preparation and nutrition lessons regardless of their socio-economic background.</p><p> </p><p> </p><p> </p><p>Organisations such as the Design and Technology Association (DATA) have promoted the practice of procuring food preparation and nutrition ingredients as part of school catering buying as a means of ensuring all children are able to participate fully in food preparation and nutrition lessons.</p><p> </p><p> </p> more like this
answering member constituency Bognor Regis and Littlehampton more like this
answering member printed Mr Nick Gibb more like this
question first answered
less than 2015-03-16T14:34:02.053Zmore like thismore than 2015-03-16T14:34:02.053Z
answering member
111
label Biography information for Nick Gibb more like this
tabling member
1521
label Biography information for Mrs Sharon Hodgson more like this
175463
registered interest false more like this
date less than 2015-01-23more like thismore than 2015-01-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Ovarian Cancer more like this
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what analysis his Department has made of the effect the Government's Strategy for UK Life Sciences on the referral of women with ovarian cancer to suitable trial centres in the UK. more like this
tabling member constituency Washington and Sunderland West more like this
tabling member printed
Mrs Sharon Hodgson remove filter
uin 221903 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-01-29more like thismore than 2015-01-29
answer text <p>The Department’s National Institute for Health Research (NIHR) supports and incentivises hospital trusts and clinicians to participate in clinical trials and studies in a number of ways.</p><p> </p><p> </p><p> </p><p>The NIHR clinical research network (CRN) provides infrastructure and resource to enable the national health service to support participation in research across all clinical specialties and the CRN performance management framework measures and encourages such participation. In 2013/14 through the CRN over 99% of NHS trusts participated in CRN portfolio studies and 86% of NHS trusts participated in CRN commercial contract portfolio studies.</p><p> </p><p> </p><p> </p><p>Decisions on how resource is to be distributed is devolved to local clinical research networks and monitored by the NIHR CRN Co-ordinating Centre on behalf of the Department; in some cases resource is provided as funded clinical sessions.</p><p> </p><p> </p><p> </p><p>Patient recruitment to UK CRN trials and studies in ovarian cancer has more than tripled from 398 in 2009/10 to 1,283 in 2013/14.</p><p> </p><p> </p><p> </p><p>The NIHR provides infrastructure for early phase clinical trials in cancer, including ovarian cancer, through its biomedical research centres, and through experimental cancer medicine centres jointly funded with Cancer Research UK.</p><p> </p><p> </p><p> </p><p>Through its training and career development programmes, the NIHR supports clinicians at all stages of their career: integrated clinical and academic training; predoctoral, doctoral and postdoctoral training; and more senior awards. The prestigious NIHR Senior Investigator award provides an additional incentive for the country’s most outstanding clinical researchers. Participation in clinical trials may form part of research undertaken through training and career development awards.</p><p> </p><p> </p><p> </p><p>The NIHR Research Design Service offers advice and support on clinical trial and other research design and methodology to researchers making funding applications and doing research within the health research system.</p><p> </p><p> </p><p> </p><p>The Government’s Mandate to NHS England requires it to ensure that the new commissioning system promotes and supports participation by NHS organisations and NHS patients in research funded by both commercial and non-commercial organisations.</p><p> </p><p> </p><p> </p><p>The Department has made no specific analysis of the effect of the <em>Strategy for UK Life Sciences </em>on the referral of women with ovarian cancer to suitable trials centres in the United Kingdom. As part of the strategy, the Government re-launched an enhanced web-based UK Clinical Trials Gateway. This provides patients and the public with authoritative and accessible information about clinical trials in the UK, including trials in ovarian cancer. The number of visits to the Gateway nearly tripled from just over 60,000 in 2011/12 to nearly 170,000 in 2013/14.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
grouped question UIN
221894 more like this
221904 more like this
question first answered
less than 2015-01-29T17:02:53.393Zmore like thismore than 2015-01-29T17:02:53.393Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
1521
label Biography information for Mrs Sharon Hodgson more like this
175464
registered interest false more like this
date less than 2015-01-23more like thismore than 2015-01-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Ovarian Cancer more like this
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what plans he has to improve the participation of women in trials for ovarian cancer treatments. more like this
tabling member constituency Washington and Sunderland West more like this
tabling member printed
Mrs Sharon Hodgson remove filter
uin 221904 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-01-29more like thismore than 2015-01-29
answer text <p>The Department’s National Institute for Health Research (NIHR) supports and incentivises hospital trusts and clinicians to participate in clinical trials and studies in a number of ways.</p><p> </p><p> </p><p> </p><p>The NIHR clinical research network (CRN) provides infrastructure and resource to enable the national health service to support participation in research across all clinical specialties and the CRN performance management framework measures and encourages such participation. In 2013/14 through the CRN over 99% of NHS trusts participated in CRN portfolio studies and 86% of NHS trusts participated in CRN commercial contract portfolio studies.</p><p> </p><p> </p><p> </p><p>Decisions on how resource is to be distributed is devolved to local clinical research networks and monitored by the NIHR CRN Co-ordinating Centre on behalf of the Department; in some cases resource is provided as funded clinical sessions.</p><p> </p><p> </p><p> </p><p>Patient recruitment to UK CRN trials and studies in ovarian cancer has more than tripled from 398 in 2009/10 to 1,283 in 2013/14.</p><p> </p><p> </p><p> </p><p>The NIHR provides infrastructure for early phase clinical trials in cancer, including ovarian cancer, through its biomedical research centres, and through experimental cancer medicine centres jointly funded with Cancer Research UK.</p><p> </p><p> </p><p> </p><p>Through its training and career development programmes, the NIHR supports clinicians at all stages of their career: integrated clinical and academic training; predoctoral, doctoral and postdoctoral training; and more senior awards. The prestigious NIHR Senior Investigator award provides an additional incentive for the country’s most outstanding clinical researchers. Participation in clinical trials may form part of research undertaken through training and career development awards.</p><p> </p><p> </p><p> </p><p>The NIHR Research Design Service offers advice and support on clinical trial and other research design and methodology to researchers making funding applications and doing research within the health research system.</p><p> </p><p> </p><p> </p><p>The Government’s Mandate to NHS England requires it to ensure that the new commissioning system promotes and supports participation by NHS organisations and NHS patients in research funded by both commercial and non-commercial organisations.</p><p> </p><p> </p><p> </p><p>The Department has made no specific analysis of the effect of the <em>Strategy for UK Life Sciences </em>on the referral of women with ovarian cancer to suitable trials centres in the United Kingdom. As part of the strategy, the Government re-launched an enhanced web-based UK Clinical Trials Gateway. This provides patients and the public with authoritative and accessible information about clinical trials in the UK, including trials in ovarian cancer. The number of visits to the Gateway nearly tripled from just over 60,000 in 2011/12 to nearly 170,000 in 2013/14.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
grouped question UIN
221894 more like this
221903 more like this
question first answered
less than 2015-01-29T17:02:53.683Zmore like thismore than 2015-01-29T17:02:53.683Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
1521
label Biography information for Mrs Sharon Hodgson more like this
175465
registered interest false more like this
date less than 2015-01-23more like thismore than 2015-01-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Ovarian Cancer more like this
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, what steps his Department is taking to improve early diagnosis of ovarian cancer. more like this
tabling member constituency Washington and Sunderland West more like this
tabling member printed
Mrs Sharon Hodgson remove filter
uin 221905 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-02-02more like thismore than 2015-02-02
answer text <p><em>Improving Outcomes: A Strategy for Cancer</em>, published on 12 January 2011, backed by over £750 million, committed over £450 million over the four years up to 2014-15 to achieve earlier diagnosis of cancer, including supporting direct general practitioner (GP) access to key diagnostic tests such as non-obstetric ultrasound to support the diagnosis of ovarian cancer. In 2012, the Department published ‘Direct access to diagnostic tests for cancer: best practice referral pathways for general practitioners’. The guide aims to raise awareness of the symptoms that require urgent referral to specialists and sets out where a direct referral for tests may benefit patients and lead to a faster diagnosis.</p><p> </p><p> </p><p> </p><p>Diagnostic Imaging Dataset collected by NHS England showed that in August 2014, GPs requested almost a quarter of all tests that may have been used to diagnose or discount cancer, under direct access arrangements. Of these, the test with the highest proportion of GP referral was ultrasounds that may have been used to diagnose ovarian cancer (45% of which were requested by GPs).</p><p> </p><p> </p><p> </p><p>The earlier diagnosis money also included some central funding for Be Clear on Cancer (BCOC) campaigns, which aim to raise awareness of the symptoms of cancer and get symptomatic patients to present earlier. Public Health England ran a regional ovarian pilot campaign which ran from 10 February to 16 March 2014 in the North West of England Television region. The campaign was aimed at women over 50, the age group most at risk of developing ovarian cancer, and their friends and family to raise awareness of bloating as a symptom of ovarian cancer and to encourage women with this symptom to visit their GP. Full evaluation results are awaited.</p><p> </p><p> </p><p> </p><p>The National Institute for health and Care Excellence’s most recent guidelines recommend offering genetic testing to people with a 10% risk of carrying a BRCA mutation, which is lower than the 20% risk previously recommended. The draft policy proposal for BRCA testing is amongst those awaiting consultation by NHS England’s Clinical Priorities Advisory Group. This will take place following the 90-day public consultation on the decision-making framework which NHS England will use to make decisions on specialised services proposals, which is now live.</p><p> </p><p> </p><p> </p><p>Following this consultation period, the Clinical Priorities Advisory Group will review the proposal and make a recommendation to the NHS England Specialised Services Committee, who will make a final decision.</p><p> </p><p> </p><p> </p><p>On 11 January NHS England announced a new independent cancer taskforce to develop a five-year action plan for cancer services to improve survival rates and save thousands of lives.</p><p> </p><p> </p><p> </p><p>The taskforce has been set up to produce a new national cancer strategy for the next five years to 2020, building on NHS England’s vision for improving cancer outcomes set out in the NHS Five Year Forward View. The taskforce will be set up in partnership with the cancer community and other health system leaders, and will be chaired by Dr Harpal Kumar, Chief Executive of Cancer Research UK. The new strategy will cover prevention, early and faster diagnosis, better treatment and care for all, recovery, reablement and living with and beyond cancer. The strategy will also cover research and innovation, end-of-life care, data and metrics, and workforce. The taskforce will produce a statement of intent by March 2015, and will aim to publish the new strategy in the summer.</p><p> </p><p> </p><p> </p><p>NHS England also launched a major early-diagnosis programme, working jointly with Cancer Research UK and Macmillan Cancer Support to test new approaches to identifying cancer more quickly. These include offering patients the option to self-refer for diagnostic tests, lowering the threshold for GP referrals, and setting up multi-disciplinary diagnostic centres, so that patients can have several tests done at the same place on the same day. NHS England’s aim is to evaluate these innovative initiatives across more than 60 centres around England, in order to collect evidence on approaches that could be implemented from 2016-17.</p><p> </p><p> </p><p> </p>
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-02-02T17:32:40.24Zmore like thismore than 2015-02-02T17:32:40.24Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
1521
label Biography information for Mrs Sharon Hodgson more like this
175466
registered interest false more like this
date less than 2015-01-23more like thismore than 2015-01-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Ovarian Cancer more like this
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, if he will publish the full evaluation report of the Be Clear on Cancer regional pilot for ovarian cancer. more like this
tabling member constituency Washington and Sunderland West more like this
tabling member printed
Mrs Sharon Hodgson remove filter
uin 221893 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-01-28more like thismore than 2015-01-28
answer text <p>Public Health England (PHE) can confirm that there will be a full and final evaluation report for the regional ovarian pilot campaign published as soon as possible, when analysis of all metrics is complete. However, in advance of a final evaluation report, the National Cancer Intelligence Network (part of PHE) aims to publish the results from the analysis of Cancer Waiting Times data for the regional ovarian pilot during the early part of 2015.</p><p> </p> more like this
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
question first answered
less than 2015-01-28T13:42:49.127Zmore like thismore than 2015-01-28T13:42:49.127Z
answering member
3918
label Biography information for Jane Ellison more like this
tabling member
1521
label Biography information for Mrs Sharon Hodgson more like this
175467
registered interest false more like this
date less than 2015-01-23more like thismore than 2015-01-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Clinical Trials more like this
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, whether his Department provides incentives to individual hospital trusts and clinicians to participate in (a) clinical trials in general and (b) clinical trials for ovarian cancer. more like this
tabling member constituency Washington and Sunderland West more like this
tabling member printed
Mrs Sharon Hodgson remove filter
uin 221894 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-01-29more like thismore than 2015-01-29
answer text <p>The Department’s National Institute for Health Research (NIHR) supports and incentivises hospital trusts and clinicians to participate in clinical trials and studies in a number of ways.</p><p> </p><p> </p><p> </p><p>The NIHR clinical research network (CRN) provides infrastructure and resource to enable the national health service to support participation in research across all clinical specialties and the CRN performance management framework measures and encourages such participation. In 2013/14 through the CRN over 99% of NHS trusts participated in CRN portfolio studies and 86% of NHS trusts participated in CRN commercial contract portfolio studies.</p><p> </p><p> </p><p> </p><p>Decisions on how resource is to be distributed is devolved to local clinical research networks and monitored by the NIHR CRN Co-ordinating Centre on behalf of the Department; in some cases resource is provided as funded clinical sessions.</p><p> </p><p> </p><p> </p><p>Patient recruitment to UK CRN trials and studies in ovarian cancer has more than tripled from 398 in 2009/10 to 1,283 in 2013/14.</p><p> </p><p> </p><p> </p><p>The NIHR provides infrastructure for early phase clinical trials in cancer, including ovarian cancer, through its biomedical research centres, and through experimental cancer medicine centres jointly funded with Cancer Research UK.</p><p> </p><p> </p><p> </p><p>Through its training and career development programmes, the NIHR supports clinicians at all stages of their career: integrated clinical and academic training; predoctoral, doctoral and postdoctoral training; and more senior awards. The prestigious NIHR Senior Investigator award provides an additional incentive for the country’s most outstanding clinical researchers. Participation in clinical trials may form part of research undertaken through training and career development awards.</p><p> </p><p> </p><p> </p><p>The NIHR Research Design Service offers advice and support on clinical trial and other research design and methodology to researchers making funding applications and doing research within the health research system.</p><p> </p><p> </p><p> </p><p>The Government’s Mandate to NHS England requires it to ensure that the new commissioning system promotes and supports participation by NHS organisations and NHS patients in research funded by both commercial and non-commercial organisations.</p><p> </p><p> </p><p> </p><p>The Department has made no specific analysis of the effect of the <em>Strategy for UK Life Sciences </em>on the referral of women with ovarian cancer to suitable trials centres in the United Kingdom. As part of the strategy, the Government re-launched an enhanced web-based UK Clinical Trials Gateway. This provides patients and the public with authoritative and accessible information about clinical trials in the UK, including trials in ovarian cancer. The number of visits to the Gateway nearly tripled from just over 60,000 in 2011/12 to nearly 170,000 in 2013/14.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
grouped question UIN
221903 more like this
221904 more like this
question first answered
less than 2015-01-29T17:02:53.537Zmore like thismore than 2015-01-29T17:02:53.537Z
answering member
4020
label Biography information for George Freeman more like this
tabling member
1521
label Biography information for Mrs Sharon Hodgson more like this
174054
registered interest false more like this
date less than 2015-01-15more like thismore than 2015-01-15
answering body
Department for Transport more like this
answering dept id 27 more like this
answering dept short name Transport more like this
answering dept sort name Transport more like this
hansard heading Motor Vehicles: Exhaust Emissions more like this
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Transport, how many ultra low emission vehicles of what models have been registered under the Plug-in Car Grant. more like this
tabling member constituency Washington and Sunderland West more like this
tabling member printed
Mrs Sharon Hodgson remove filter
uin 220960 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2015-01-22more like thismore than 2015-01-22
answer text <p><strong> </strong></p><p>17601 plug-in car grant payments have been made between the start of the scheme and 31 December 2014.</p><p> </p><p>These were for the following models:</p><p> </p><table><tbody><tr><td><p><strong>Manufacturer</strong></p></td><td><p><strong>Model </strong></p></td><td><p><strong>No. of claims paid</strong></p></td></tr><tr><td><p>Nissan</p></td><td><p>Leaf</p></td><td><p>6398</p></td></tr><tr><td><p>Mitsubishi</p></td><td><p>Outlander</p></td><td><p>4354</p></td></tr><tr><td><p>Toyota</p></td><td><p>Plug-in Prius</p></td><td><p>1206</p></td></tr><tr><td><p>Vauxhall</p></td><td><p>Ampera</p></td><td><p>1139</p></td></tr><tr><td><p>Renault</p></td><td><p>Zoe</p></td><td><p>873</p></td></tr><tr><td><p>BMW</p></td><td><p>i3 REV</p></td><td><p>624</p></td></tr><tr><td><p>BMW</p></td><td><p>i3 BEV</p></td><td><p>535</p></td></tr><tr><td><p>Tesla</p></td><td><p>Model S</p></td><td><p>515</p></td></tr><tr><td><p>Peugeot</p></td><td><p>iOn</p></td><td><p>343</p></td></tr><tr><td><p>Mercedes</p></td><td><p>Smart Fortwo</p></td><td><p>268</p></td></tr><tr><td><p>Mitsubishi</p></td><td><p>i-Miev</p></td><td><p>206</p></td></tr><tr><td><p>BMW</p></td><td><p>i8</p></td><td><p>194</p></td></tr><tr><td><p>Citroen</p></td><td><p>C-Zero</p></td><td><p>193</p></td></tr><tr><td><p>Porsche</p></td><td><p>Panamera</p></td><td><p>191</p></td></tr><tr><td><p>Volvo</p></td><td><p>v60</p></td><td><p>177</p></td></tr><tr><td><p>Chevrolet</p></td><td><p>Volt</p></td><td><p>130</p></td></tr><tr><td><p>VW</p></td><td><p>e-Up</p></td><td><p>89</p></td></tr><tr><td><p>Renault</p></td><td><p>Fluence</p></td><td><p>82</p></td></tr><tr><td><p>VW</p></td><td><p>e-Golf</p></td><td><p>46</p></td></tr><tr><td><p>Audi</p></td><td><p>E-tron</p></td><td><p>37</p></td></tr><tr><td><p>MIA</p></td><td><p>Mia</p></td><td><p>1</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr></tbody></table><p> </p><p> </p><p>The total number of PICG claims to end December 2014 is 22125. The difference between this figure, and the total payments figure above, represents claims currently being processed in the system.</p><p> </p><p>The Department for Transport also publishes registration data per model. The latest annual data is available here:</p><p><a href="https://www.gov.uk/government/statistical-data-sets/veh01-vehicles-registered-for-the-first-time" target="_blank">https://www.gov.uk/government/statistical-data-sets/veh01-vehicles-registered-for-the-first-time</a></p><p> </p><p> </p>
answering member constituency Scarborough and Whitby more like this
answering member printed Mr Robert Goodwill more like this
question first answered
less than 2015-01-22T11:39:12.44Zmore like thismore than 2015-01-22T11:39:12.44Z
answering member
1562
label Biography information for Sir Robert Goodwill more like this
tabling member
1521
label Biography information for Mrs Sharon Hodgson more like this
169869
registered interest false more like this
date less than 2014-12-11more like thismore than 2014-12-11
answering body
Cabinet Office more like this
answering dept id 53 more like this
answering dept short name Cabinet Office more like this
answering dept sort name Cabinet Office more like this
hansard heading Tickets: Fraud more like this
house id 1 remove filter
legislature
25259
pref label House of Commons more like this
question text To ask the Minister for the Cabinet Office, how many reports of ticket fraud have been made to Action Fraud in the last full year for which figures are available; and how many such reports related to tickets purchased through legitimate secondary ticketing platforms. more like this
tabling member constituency Washington and Sunderland West more like this
tabling member printed
Mrs Sharon Hodgson remove filter
uin 218378 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2014-12-16more like thismore than 2014-12-16
answer text <p>The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.</p><p> </p> more like this
answering member constituency Reading East more like this
answering member printed Mr Rob Wilson more like this
question first answered
less than 2014-12-16T16:57:44.887Zmore like thismore than 2014-12-16T16:57:44.887Z
answering member
1556
label Biography information for Mr Rob Wilson more like this
attachment
1
file name PQ 218378 ONS 464.pdf more like this
title ONS Letter to Member - Ticket Fraud more like this
tabling member
1521
label Biography information for Mrs Sharon Hodgson more like this